{
    "Trade/Device Name(s)": [
        "Aptima Chlamydia trachomatis Assay",
        "Aptima CT Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K230451",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063451"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MKZ"
    ],
    "Summary Letter Date": "February 16, 2023",
    "Summary Letter Received Date": "February 21, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3120"
    ],
    "Regulation Name(s)": [
        "Chlamydia Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis ribosomal RNA (rRNA)"
    ],
    "Specimen Type(s)": [
        "Patient-collected vaginal swab",
        "Female urine",
        "Male urine"
    ],
    "Specimen Container(s)": [
        "Specimen transport tube",
        "Aptima Multitest Swab Specimen Collection Kit"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification test (NAAT)",
        "Target capture",
        "Transcription-mediated amplification (TMA)",
        "Hybridization protection assay (HPA)",
        "Chemiluminescent detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Target capture",
        "Hybridization protection assay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Aptima Chlamydia trachomatis assay utilizing nucleic acid amplification on the Panther system for detection of CT rRNA in vaginal swab and urine specimens.",
    "Indications for Use Summary": "Qualitative NAAT for detection of Chlamydia trachomatis ribosomal RNA to aid in diagnosis of chlamydia urogenital disease using Panther System with patient-collected vaginal swab and male/female urine specimens.",
    "fda_folder": "Microbiology"
}